✦ LIBER ✦

Preclinical metabolism and pharmacokinetics of NVS-CRF38, a potent and orally bioavailable corticotropin-releasing factor receptor 1 antagonist

✍ Scribed by Stringer, Rowan A.; Weber, Eckhard; Culshaw, Andrew; McKenna, Jeff; Williams, Gareth; Rose, Jonathan; Sohal, Bindi

Book ID: 124076964
Publisher: Informa plc
Year: 2014
Tongue: English
Weight: 554 KB
Volume: 44
Category: Article
ISSN: 0049-8254
DOI: 10.3109/00498254.2014.907458

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In Vitro and In Vivo Metabolism and Phar

In Vitro and In Vivo Metabolism and Pharmacokinetics of BMS-562086, a Potent and Orally Bioavailable Corticotropin-Releasing Factor-1 Receptor Antagonist

✍ Zhou, L.; Dockens, R. C.; Liu-Kreyche, P.; Grossman, S. J.; Iyer, R. A. 📂 Article 📅 2012 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 466 KB

Synthesis and SAR of 8-Arylquinolines as

Synthesis and SAR of 8-Arylquinolines as Potent Corticotropin-Releasing Factor1 (CRF1) Receptor Antagonists.

✍ Charles Q. Huang; Keith Wilcoxen; James R. McCarthy; Mustapha Haddach; Thomas R. 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 100 KB 👁 2 views

## Abstract For Abstract see ChemInform Abstract in Full Text.

Synthesis and Structure−Activity Relatio

Synthesis and Structure−Activity Relationships of 8-(Pyrid-3-yl)pyrazolo[1,5-a]-1,3,5-triazines: Potent, Orally Bioavailable Corticotropin Releasing Factor Receptor-1 (CRF1) Antagonists

✍ Gilligan, Paul J.; Clarke, Todd; He, Liqi; Lelas, Snjezana; Li, Yu-Wen; Heman, K 📂 Article 📅 2009 🏛 American Chemical Society 🌐 English ⚖ 140 KB

ChemInform Abstract: Discovery of NBI-77

ChemInform Abstract: Discovery of NBI-77860/GSK561679, a Potent Corticotropin-Releasing Factor (CRF1) Receptor Antagonist with Improved Pharmacokinetic Properties.

✍ John P. Williams; et al. et al. 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 21 KB

Design, Synthesis, and SAR of 2-Dialkyla

Design, Synthesis, and SAR of 2-Dialkylamino-4-arylpyrimidines as Potent and Selective Corticotropin-Releasing Factor1 (CRF1) Receptor Antagonists.

✍ Charles Q. Huang; Dimitri E. Grigoriadis; Zhengyu Liu; James R. McCarthy; John R 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 62 KB 👁 2 views

NBI 30775 (R121919): An Orally Active An

NBI 30775 (R121919): An Orally Active Antagonist of the Corticotropin-Releasing Factor (CRF) Type-1 Receptor for Treatment of Anxiety and Depression

✍ Chen Chen; Dimitri E. Grigoriadis 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 8 KB